<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName JATS-journalpublishing1.dtd?><?SourceDTD.Version 1.1?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pathogens</journal-id><journal-id journal-id-type="iso-abbrev">Pathogens</journal-id><journal-id journal-id-type="publisher-id">pathogens</journal-id><journal-title-group><journal-title>Pathogens</journal-title></journal-title-group><issn pub-type="epub">2076-0817</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7915666</article-id><article-id pub-id-type="pmid">33562567</article-id><article-id pub-id-type="doi">10.3390/pathogens10020175</article-id><article-id pub-id-type="publisher-id">pathogens-10-00175</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Antitrypanosomal and Antileishmanial Activity of Chalcones and Flavanones from <italic>Polygonum salicifolium</italic></article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zheoat</surname><given-names>Ahmed M.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref><xref ref-type="aff" rid="af2-pathogens-10-00175">2</xref></contrib><contrib contrib-type="author"><name><surname>Alenezi</surname><given-names>Samya</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4484-3678</contrib-id><name><surname>Elmahallawy</surname><given-names>Ehab Kotb</given-names></name><xref ref-type="aff" rid="af3-pathogens-10-00175">3</xref><xref ref-type="aff" rid="af4-pathogens-10-00175">4</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-4918-1423</contrib-id><name><surname>Ungogo</surname><given-names>Marzuq A.</given-names></name><xref ref-type="aff" rid="af3-pathogens-10-00175">3</xref><xref ref-type="aff" rid="af5-pathogens-10-00175">5</xref></contrib><contrib contrib-type="author"><name><surname>Alghamdi</surname><given-names>Ali H.</given-names></name><xref ref-type="aff" rid="af3-pathogens-10-00175">3</xref><xref ref-type="aff" rid="af6-pathogens-10-00175">6</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1094-7604</contrib-id><name><surname>Watson</surname><given-names>David G.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-8013-2702</contrib-id><name><surname>Igoli</surname><given-names>John O.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref><xref ref-type="aff" rid="af7-pathogens-10-00175">7</xref></contrib><contrib contrib-type="author"><name><surname>Gray</surname><given-names>Alexander I.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-9963-1827</contrib-id><name><surname>de Koning</surname><given-names>Harry P.</given-names></name><xref ref-type="aff" rid="af3-pathogens-10-00175">3</xref><xref rid="c1-pathogens-10-00175" ref-type="corresp">*</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-1967-3603</contrib-id><name><surname>Ferro</surname><given-names>Valerie A.</given-names></name><xref ref-type="aff" rid="af1-pathogens-10-00175">1</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Yurchenko</surname><given-names>Vyacheslav</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Colella</surname><given-names>Vito</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-pathogens-10-00175"><label>1</label>Strathclyde Institute of Pharmacy and Biomedical Sciences, University of Strathclyde, Glasgow G4 0RE, UK; <email>ahmedpharm.2013@gmail.com</email> (A.M.Z.); <email>s-alenezi@strath.ac.uk</email> (S.A.); <email>D.G.Watson@strath.ac.uk</email> (D.G.W.); <email>igolij@gmail.com</email> (J.O.I.); <email>a.i.gray345@gmail.com</email> (A.I.G.); <email>v.a.ferro@strath.ac.uk</email> (V.A.F.)</aff><aff id="af2-pathogens-10-00175"><label>2</label>Al-Manara College for Medical Sciences, Misan 10028, Iraq</aff><aff id="af3-pathogens-10-00175"><label>3</label>Institute of Infection, Immunity and Inflammation, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G12 8TA, UK; <email>eehaa@unileon.es</email> (E.K.E.); <email>2226184U@student.gla.ac.uk</email> (M.A.U.); <email>Ayfan24@hotmail.com</email> (A.H.A.)</aff><aff id="af4-pathogens-10-00175"><label>4</label>Department of Zoonoses, Faculty of Veterinary Medicine, Sohag University, Sohag 82524, Egypt</aff><aff id="af5-pathogens-10-00175"><label>5</label>Department of Veterinary Pharmacology and Toxicology, Faculty of Veterinary Medicine, Ahmadu Bello University, Zaria 810107, Nigeria</aff><aff id="af6-pathogens-10-00175"><label>6</label>Biology Department, Faculty of Science, Albaha University, Albaha 7738-65799, Saudi Arabia</aff><aff id="af7-pathogens-10-00175"><label>7</label>Phytochemistry Research Group, Department of Chemistry, University of Agriculture, Makurdi 2373, Nigeria</aff><author-notes><corresp id="c1-pathogens-10-00175"><label>*</label>Correspondence: <email>Harry.de-Koning@glasgow.ac.uk</email></corresp></author-notes><pub-date pub-type="epub"><day>05</day><month>2</month><year>2021</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2021</year></pub-date><volume>10</volume><issue>2</issue><elocation-id>175</elocation-id><history><date date-type="received"><day>09</day><month>12</month><year>2020</year></date><date date-type="accepted"><day>02</day><month>2</month><year>2021</year></date></history><permissions><copyright-statement>&#x000a9; 2021 by the authors.</copyright-statement><copyright-year>2021</copyright-year><license license-type="open-access"><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract><p>Trypanosomiasis and leishmaniasis are a group of neglected parasitic diseases caused by several species of parasites belonging to the family Trypansomatida. The present study investigated the antitrypanosomal and antileishmanial activity of chalcones and flavanones from <italic>Polygonum salicifolium</italic>, which grows in the wetlands of Iraq. The phytochemical evaluation of the plant yielded two chalcones, 2&#x02032;,4&#x02032;-dimethoxy-6&#x02032;-hydroxychalcone and 2&#x02032;,5&#x02032;-dimethoxy-4&#x02032;,6&#x02032;-dihydroxychalcone, and two flavanones, 5,7-dimethoxyflavanone and 5,8-dimethoxy-7-hydroxyflavanone. The chalcones showed a good antitrypanosomal and antileishmanial activity while the flavanones were inactive. The EC<sub>50</sub> values for 2&#x02032;,4&#x02032;-dimethoxy-6&#x02032;-hydroxychalcone against <italic>Trypanosoma brucei brucei</italic> (0.5 &#x003bc;g/mL), <italic>T. congolense</italic> (2.5 &#x003bc;g/mL), and <italic>Leishmania mexicana</italic> (5.2 &#x003bc;g/mL) indicated it was the most active of the compounds. None of the compounds displayed any toxicity against a human cell line, even at 100 &#x000b5;g/mL, or cross-resistance with first line clinical trypanocides, such as diamidines and melaminophenyl arsenicals. Taken together, our study provides significant data in relation to the activity of chalcones and flavanones from <italic>P. salicifolium</italic> against both parasites in vitro. Further future research is suggested in order to investigate the mode of action of the extracted chalcones against the parasites.</p></abstract><kwd-group><kwd><italic>Polygonum salicifolium</italic></kwd><kwd>chalcone</kwd><kwd>flavanone</kwd><kwd><italic>Leishmania mexicana</italic></kwd><kwd><italic>Trypanosoma brucei brucei</italic></kwd><kwd><italic>Trypanosoma congolense</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-pathogens-10-00175"><title>1. Introduction</title><p>The marshes of Iraq are considered to be the largest ecosystem in the Middle East and Western Eurasia [<xref rid="B1-pathogens-10-00175" ref-type="bibr">1</xref>]. More than one hundred species of aquatic and amphibious plants have been recorded in this area. Ancient Mesopotamians used some of the plants for a range of medicinal and culinary purposes. In modern Mesopotamia, Marsh Arabs also use plants from the marshes for medicinal and healing purposes [<xref rid="B1-pathogens-10-00175" ref-type="bibr">1</xref>]. <italic>Polygonum salicifolium</italic> is a common species found in the wetlands, and it is an important source of food in the localities [<xref rid="B2-pathogens-10-00175" ref-type="bibr">2</xref>]. There is little information on the phytochemical constituents and the potential biological activities of this plant. Previous studies on <italic>P. salicifolium</italic> indicated flavonoid glycosides [<xref rid="B3-pathogens-10-00175" ref-type="bibr">3</xref>] and flavonol glycosides [<xref rid="B4-pathogens-10-00175" ref-type="bibr">4</xref>] as predominant constituents in the aerial parts of the plant. These classes of compounds are well known for their antioxidant effects [<xref rid="B4-pathogens-10-00175" ref-type="bibr">4</xref>]. Midiwo et al. [<xref rid="B5-pathogens-10-00175" ref-type="bibr">5</xref>] described the wide use of Polygonaceae as ethnobotanical treatments for a variety of wounds and ailments, including as anthelminthics. Specifically, four <italic>Polygonum</italic> spp. were mentioned, with applications against ectoparasites and syphilis among other uses [<xref rid="B5-pathogens-10-00175" ref-type="bibr">5</xref>,<xref rid="B6-pathogens-10-00175" ref-type="bibr">6</xref>]. <italic>Polygonum acuminatum</italic> Kunth has also been reported to possess antimalarial properties [<xref rid="B7-pathogens-10-00175" ref-type="bibr">7</xref>]. Very recently, other antiparasite properties of <italic>Polygonum</italic> species have been reported, including anthelminthic [<xref rid="B8-pathogens-10-00175" ref-type="bibr">8</xref>,<xref rid="B9-pathogens-10-00175" ref-type="bibr">9</xref>] and antiprotozoal activities, the latter against an important parasite of fresh water fish, <italic>Ichthyophthirius multifiliis</italic> [<xref rid="B10-pathogens-10-00175" ref-type="bibr">10</xref>]. However, <italic>Polygonum</italic>-derived antiparasitics have yet to be isolated and positively identified.</p><p>This report focusses on the isolation of phytochemicals from the aerial parts of <italic>P. salicifolium</italic>, and their antiparasitic activities. Specifically, we tested compounds against <italic>Trypanosoma brucei brucei</italic>, <italic>T. congolense,</italic> and <italic>Leishmania mexicana</italic>. The <italic>T. brucei</italic> subspecies <italic>T. b. gambiense</italic> and <italic>T. b. rhodesiense</italic> are the etiological agents of human African trypanosomiasis [<xref rid="B11-pathogens-10-00175" ref-type="bibr">11</xref>], commonly known as sleeping sickness, whereas <italic>T. congolense</italic> is the most important pathogen causing the important livestock disease, nagana, in Sub-Saharan Africa [<xref rid="B12-pathogens-10-00175" ref-type="bibr">12</xref>]. <italic>L. mexicana</italic> is one of the parasites causing cutaneous leishmaniasis, a condition that is highly prevalent throughout the Middle East [<xref rid="B13-pathogens-10-00175" ref-type="bibr">13</xref>], whereas visceral leishmaniasis is also increasing around the Mediterranean Sea [<xref rid="B14-pathogens-10-00175" ref-type="bibr">14</xref>] and in Black Sea countries [<xref rid="B15-pathogens-10-00175" ref-type="bibr">15</xref>,<xref rid="B16-pathogens-10-00175" ref-type="bibr">16</xref>]. Drugs for these conditions are old and inadequate [<xref rid="B17-pathogens-10-00175" ref-type="bibr">17</xref>,<xref rid="B18-pathogens-10-00175" ref-type="bibr">18</xref>,<xref rid="B19-pathogens-10-00175" ref-type="bibr">19</xref>], and the current report is part of our investigations into whether new medicines can be developed from local medicinal plants [<xref rid="B20-pathogens-10-00175" ref-type="bibr">20</xref>,<xref rid="B21-pathogens-10-00175" ref-type="bibr">21</xref>,<xref rid="B22-pathogens-10-00175" ref-type="bibr">22</xref>,<xref rid="B23-pathogens-10-00175" ref-type="bibr">23</xref>] or propolis [<xref rid="B24-pathogens-10-00175" ref-type="bibr">24</xref>,<xref rid="B25-pathogens-10-00175" ref-type="bibr">25</xref>,<xref rid="B26-pathogens-10-00175" ref-type="bibr">26</xref>] as a sustainable solution for developing countries [<xref rid="B27-pathogens-10-00175" ref-type="bibr">27</xref>], and to validate ethnopharmacological practice [<xref rid="B21-pathogens-10-00175" ref-type="bibr">21</xref>].</p></sec><sec sec-type="results" id="sec2-pathogens-10-00175"><title>2. Results</title><sec id="sec2dot1-pathogens-10-00175"><title>2.1. Isolation and Identification of Compounds</title><p>The compound 2&#x02032;,4&#x02032;-dimethoxy-6&#x02032;-hydroxychalcone (<bold>1</bold>) (<xref ref-type="fig" rid="pathogens-10-00175-f001">Figure 1</xref>) was obtained as a yellow solid (50 mg) from the combined column fractions 9&#x02013;11 of the hexane extract. It was purified by preparative thin layer chromatography (PTLC), using 30% EtOAc in hexane as the mobile phase. On TLC (Rf = 0.48), the compound appeared as a yellow spot, but under short UV, it appeared as a dark spot. However, the compound appeared as a brown spot after spraying with p-anisaldehyde-sulfuric acid and heating. Its mass ion [M+H]<sup>+</sup> observed at <italic>m</italic>/<italic>z</italic> 285.0, suggested a molecular formula of C<sub>17</sub>H<sub>16</sub>O<sub>4</sub> (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S1</xref>). The proton spectrum indicated the presence of seven aromatic protons, which needed to be from two phenyl rings (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S2</xref>). Based on integration and <sup>1</sup>H-<sup>1</sup>H couplings in the COSY spectrum, one of the rings was tetra and the other mono substituted (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S3</xref>). Protons H-3, H-4, and H-5 on the mono-substituted ring appeared as a multiplets between &#x003b4;<sub>H</sub> 7.37 and 7.43 ppm (3H, m), while protons H-2 and H-6 appeared as a doublet at 7.62 (2H, dd, <italic>J</italic> = 7.6, 1.8). The signals at 3.86 (3H, s) and 3.95 (3H, s) were assigned to 4&#x02032;- and 2&#x02032;-OCH<sub>3</sub>, respectively, while the one at &#x003b4;<sub>H</sub> 14.30 ppm was attributed to the H-bonded or chelated 6&#x02032;-OH. The meta-coupled aromatic protons at 6.14 (1H, d, <italic>J</italic> = 2.4) and 5.99 (1H, d, <italic>J</italic> = 2.4) were assigned to H-5&#x02032; and H-3&#x02032;, respectively. Two trans-coupled olefinic protons were observed at &#x003b4;<sub>H</sub> 7.91 (1H, <italic>d</italic>, <italic>J</italic> = 15.6, &#x003b1;-H) and 7.83 (1H, d, <italic>J</italic> = 15.6, &#x003b2;-H). The carbon spectrum indicated the presence of 12 aromatic and two olefinic carbon signals (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S4</xref>). The signal at &#x003b4;<sub>C</sub> 192.5 was attributed to the carbonyl carbon of the chalcone, while the signals at 127.4 and 142.2 ppm were assigned to the &#x003b1;- and &#x003b2;-olefinic carbons, respectively. The rest of the signals were for the aromatic ring carbons. These assignments were further supported by the HMBC and HSQC spectra for the compound (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figures S5 and S6</xref>). The hydroxyl proton showed long range correlations (<sup>3</sup><italic>J</italic>) to C-5&#x02032; and C-1&#x02032;, and (<sup>2</sup><italic>J</italic>) to C-6&#x02032;. Hence, it must be attached at C-6&#x02032;. The methoxy group protons at &#x003b4;<sub>H</sub> 3.95 and 3.86 showed long range correlations to the carbons at &#x003b4;<sub>C</sub> 162.4 (C-2&#x02032;) and 166.1 (C-4&#x02032;), respectively; hence, they must also be attached to these carbons. The full chemical shift assignments are given in <xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Table S1</xref>. It has been previously reported from Kava Plant (<italic>Piper methysticum</italic>) [<xref rid="B28-pathogens-10-00175" ref-type="bibr">28</xref>].</p><p>Compound <bold>2,</bold> identified as 2&#x02032;,5&#x02032;-dimethoxy-4&#x02032;,6&#x02032;-dihydroxychalcone (<xref ref-type="fig" rid="pathogens-10-00175-f001">Figure 1</xref>), was also obtained as a yellow solid (40 mg) from the combined column fractions 33&#x02013;37 of the hexane extract. It was also purified by PTLC using 40% EtOAc in hexane as the mobile phase. Compound <bold>2</bold> also appeared as a yellow spot on TLC (Rf = 0.53). Under short UV, it appeared as a dark spot, which turned into a brown spot after spraying with p-anisaldehyde-sulfuric acid, followed by heating. The positive mode HRLC-MS spectrum showed a molecular ion [M+H]<sup>+</sup> at <italic>m</italic>/<italic>z</italic> 301.1100 (Calc 301.1076, C<sub>17</sub>H<sub>17</sub>O<sub>5</sub>), suggesting a molecular formula of C<sub>17</sub>H<sub>16</sub>O<sub>5</sub> (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S7</xref>). The proton spectrum was similar to that of compound <bold>1</bold>, except for the presence of six aromatic protons (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S8</xref>). The difference was due to an extra substitution in the A ring, as the mono-substituted ring protons were still identical. Based on the integration and <sup>1</sup>H-<sup>1</sup>H couplings in the COSY spectrum, this was confirmed by the disappearance of the meta-coupled protons in compound <bold>1</bold>, now replaced by a proton singlet in compound <bold>2</bold> (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S9</xref>). The two methoxy group signals appeared at &#x003b4;<sub>H</sub> 3.83 ppm (3H, s) and 3.86 ppm (3H, s), while the chelated 6&#x02032;-OH was at 14.28 ppm. The aromatic singlet at &#x003b4; 5.99 ppm (s) was assigned to H-3&#x02032;. The trans-olefinic protons were also observed at &#x003b4;<sub>H</sub> 7.82 ppm (1H, d, <italic>J</italic> = 15.6, &#x003b1;-H) and 7.72 (1H, d, <italic>J</italic> = 15.6, &#x003b2;-H). The <sup>13</sup>C spectrum of this compound showed 17 signals identical to compound <bold>1</bold>, but with one aromatic CH less and replaced by a quaternary carbon signal at 128.4 ppm (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary material S10</xref>). Long range correlations in the HMBC (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S11</xref>), indicated the hydroxyl proton at &#x003b4;<sub>H</sub> 14.20 ppm showed correlations with C1&#x02032;, C-6&#x02032;, and C-5&#x02032;, while the methoxy protons at 3.83 and 3.86 showed correlations to C-2&#x02032; (&#x003b4;<sub>C</sub> 158.8) and C-5&#x02032; (&#x003b4;<sub>C</sub> 128.4), respectively. Using these long-range correlations and the HSQC (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S12</xref>) spectrum, the complete chemical shift assignments (<xref ref-type="app" rid="app1-pathogens-10-00175">Table S2</xref>) were made. Compound <bold>2</bold> was previously isolated from the leaves of <italic>P. limbatum</italic> [<xref rid="B29-pathogens-10-00175" ref-type="bibr">29</xref>,<xref rid="B30-pathogens-10-00175" ref-type="bibr">30</xref>].</p><p>Compound <bold>3,</bold> identified as 5,7-dimethoxyflavanone (<xref ref-type="fig" rid="pathogens-10-00175-f001">Figure 1</xref>), was obtained as a yellow solid (15 mg) from the combined column fractions 70&#x02013;76 of the hexane extract. It was similarly purified by PTLC using 70% EtOAc in hexane as the mobile phase. On TLC (Rf = 0.37), it appeared as a dark spot when visualized under short UV and as a light blue under long UV. The spot of the compound turned yellow after spraying with p-anisaldehyde-sulfuric acid reagent followed by heating. Its mass ion [M+H]<sup>+</sup> was observed at <italic>m</italic>/<italic>z</italic> 285.1, suggesting a molecular formula of C<sub>17</sub>H<sub>16</sub>O<sub>4</sub> (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Spectrum S13</xref>). The proton spectrum showed the presence of seven aromatic protons (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Spectrum S14</xref>), which was suggested to be from a flavanone nucleus. Based on the integration and <sup>1</sup>H-<sup>1</sup>H couplings (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S15</xref>) in the COSY spectrum, the proton signal at &#x003b4;<sub>H</sub> 5.44 ppm (1H, dd, <italic>J</italic> = 13.1, 2.8) showed an ABX spin system with the axial proton at &#x003b4;<sub>H</sub> 3.05 ppm (1H, dd, J = 16.5, 13.2) and the equatorial one at &#x003b4;<sub>H</sub> 2.83 ppm (1H- dd, J =16.5, 2.8). Protons H-2&#x02032;, H-3&#x02032;, H-4&#x02032;, H-5&#x02032;, and H-6&#x02032; on the mono-substituted B ring appeared as a multiplet, between &#x003b4;<sub>H</sub> 7.37 and 7.45 ppm (5H, m). The meta-coupled aromatic protons at &#x003b4;<sub>H</sub> 6.13 ppm (1H, d, <italic>J</italic> = 2.3) and 6.19 ppm (1H, d, <italic>J</italic> = 2.3) were assigned to H-6 and H-8, respectively. The signals at &#x003b4; 3.85 ppm (3H, s) and 3.98 ppm (3H, s) were assigned to C-7 and C-5-OCH<sub>3</sub>, respectively. The <sup>13</sup>C spectrum of this compound (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S16</xref>) showed the presence of 17 carbon atoms, corresponding to carbon atoms of the flavanone moiety and two methoxy groups. The methoxy group protons at &#x003b4;<sub>H</sub> 3.85 and 3.98 ppm showed long range correlations to the carbons at &#x003b4;c at 166.0 (C-7) and 162.3 (C-5), respectively (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figures S17 and S18</xref>); hence, they must also be attached to these carbons. These assignments were further supported by the HMBC spectrum for the compound, and the full chemical shift assignments are given in <xref ref-type="app" rid="app1-pathogens-10-00175">Table S3</xref>. Compound <bold>3</bold> was also isolated from Kava <italic>(Piper methysticum)</italic> roots [<xref rid="B31-pathogens-10-00175" ref-type="bibr">31</xref>].</p><p>Compound <bold>4,</bold> identified as 5,8-dimethoxy-7-hydroxyflavanone (<xref ref-type="fig" rid="pathogens-10-00175-f001">Figure 1</xref>), was obtained as a white solid (10.0 mg) from the PTLC purification of fractions 90-97 of the hexane extract of <italic>P. salicifolium</italic>, using 10% (<italic>v</italic>/<italic>v</italic>) MeOH in EtOAc as the mobile phase. On the TLC (Rf = 0.32 in EtOAc: hexane 7:3), it appeared as a dark spot under short UV and a white spot under long UV, which turned yellow upon spraying with p-anisaldehyde-sulfuric acid reagent followed by heating. Its mass ion [M+H]<sup>+</sup> at <italic>m</italic>/<italic>z</italic> 301.2 supported a molecular formula of C<sub>17</sub>H<sub>16</sub>O<sub>5</sub> (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S19</xref>). The proton spectrum was similar to that of compound <bold>3</bold>, but showed six aromatic protons (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S20</xref>). The difference was due to an extra substitution in the A ring, whereas the mono-substituted ring protons were still identical. This was confirmed by the disappearance of the meta-coupled protons in compound <bold>3</bold>, now replaced by a proton singlet in compound <bold>4</bold>. The proton signal at &#x003b4;<sub>H</sub> 5.45 ppm (1H, dd, <italic>J</italic> = 12.9, 3.0) also showed an ABX spin system with the axial proton at &#x003b4;<sub>H</sub> 3.0 ppm (1H, dd, <italic>J</italic> = 16.6, 13.0) and the equatorial one at &#x003b4;<sub>H</sub> 2.83 ppm (1H, dd, <italic>J</italic> = 16.6, 3.1; <xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figure S21</xref>). The two methoxy groups appeared at &#x003b4;<sub>H</sub> 3.86 and 3.85 ppm. The appearance of the proton at &#x003b4;<sub>H</sub> 6.19 ppm as a singlet (1H, s), and the long-range coupling with a hydroxyl bearing carbon (C-7) and with the carbon bearing a methoxy group (C-5) confirmed the penta substitution of the A ring. The signals between &#x003b4;<sub>H</sub> 7.35 and 7.47 ppm (5H, m) were attributed to the five protons of the unsubstituted B ring. The signals at &#x003b4;<sub>H</sub> 3.85 ppm (3H, s) and 3.86 ppm (3H s,) were assigned to the C-5 and C-8-OCH<sub>3</sub> groups, respectively. The <sup>13</sup>C spectrum of the compound (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Spectrum S22</xref>) showed the presence of 17 signals, corresponding to carbon atoms of the flavanone structure and two methoxy groups. Using the HMBC and HSQC spectra for the compound (<xref ref-type="app" rid="app1-pathogens-10-00175">Supplementary Materials Figures S23 and S24</xref>), complete chemical shift assignments (<xref ref-type="app" rid="app1-pathogens-10-00175">Table S4</xref>) were made. Compound <bold>4</bold> was previously isolated from the aerial parts of <italic>Polygonum senegalensis</italic> [<xref rid="B5-pathogens-10-00175" ref-type="bibr">5</xref>].</p></sec><sec id="sec2dot2-pathogens-10-00175"><title>2.2. Anti-Kinetoplastid and Cytotoxic Activity of the Isolated Compounds</title><p>The four compounds were tested for activity against the following three kinetoplastid pathogens: <italic>Trypanosoma brucei brucei</italic>, <italic>Trypanosoma congolense,</italic> and <italic>Leishmania mexicana</italic>. For the two <italic>Trypanosoma</italic> species, the compounds were tested in parallel against strains that were resistant to the most common trypanocides. <italic>T. b. brucei</italic> B48 is highly resistant to the entire classes of diamidines and melaminophenyl arsenicals [<xref rid="B28-pathogens-10-00175" ref-type="bibr">28</xref>], and <italic>T. congolense</italic> DA-Res was rendered resistant to diminazene aceturate by means of in vitro exposure to the drug. The highest activity was observed against <italic>T. b. brucei</italic>, followed by <italic>T. congolense</italic>, but only a moderate activity was observed against <italic>L. mexicana</italic> (<xref rid="pathogens-10-00175-t001" ref-type="table">Table 1</xref>). For the drug-resistant trypanosome strains, highly significant resistance to diamidines was confirmed, but there was no cross-resistance with the chalcones and flavanones. None of the four compounds displayed measurable toxicity against the human foreskin fibroblast (HFF) cell line at the highest concentration tested (100 &#x000b5;g/mL; <xref rid="pathogens-10-00175-t001" ref-type="table">Table 1</xref>). Compound <bold>1</bold> was the most active against all kinetoplastid species and strains, displaying a promising EC<sub>50</sub> of 0.58 &#x000b5;g/mL (2.04 &#x000b5;M) against <italic>T. b. brucei</italic> in our standard resazurin-based assay. Chalcone <bold>2</bold> was the second-most active, showing about 8-fold, 4-fold, and 5-fold less activity against <italic>T. b. brucei</italic>, <italic>T. congolense,</italic> and <italic>L. mexicana</italic>, respectively (<xref rid="pathogens-10-00175-t001" ref-type="table">Table 1</xref>). While this dataset of two chalcones is self-evidently insufficient for a structure&#x02013;activity relationship (SAR) analysis, it is clear that the position of the hydroxy and methoxy groups on ring A (<xref ref-type="fig" rid="pathogens-10-00175-f001">Figure 1</xref>) influenced the trypanocidal activity without increasing the toxicity.</p></sec></sec><sec sec-type="discussion" id="sec3-pathogens-10-00175"><title>3. Discussion</title><p>Leishmaniasis and trypanosomiasis are a heterogeneous group of neglected parasitic diseases of public health concern [<xref rid="B29-pathogens-10-00175" ref-type="bibr">29</xref>]. These diseases remain endemic in several countries worldwide [<xref rid="B29-pathogens-10-00175" ref-type="bibr">29</xref>,<xref rid="B30-pathogens-10-00175" ref-type="bibr">30</xref>,<xref rid="B31-pathogens-10-00175" ref-type="bibr">31</xref>]. The search for novel drugs remains one of the major control strategies for combating these diseases [<xref rid="B32-pathogens-10-00175" ref-type="bibr">32</xref>], as safe and effective treatment of the various forms of leishmaniasis and trypanosomiasis remains a major challenge [<xref rid="B19-pathogens-10-00175" ref-type="bibr">19</xref>,<xref rid="B32-pathogens-10-00175" ref-type="bibr">32</xref>]. The present study provides data related to the investigation into the effect of <italic>P. salicifolium</italic> chalcones and flavanones against <italic>Trypanosoma</italic> species and <italic>Leishmania</italic> promastigotes. This work also investigated the effect of compounds against a human cell line and cross-resistance with first line clinical trypanocides such as diamidines and melaminophenyl arsenicals. The phytochemical investigation of the hexane extract of <italic>P. salicifolium</italic> led to the isolation of two chalcones&#x02014;compound (<bold>1</bold>), and compound (<bold>2</bold>)&#x02014;and two flavanones&#x02014;compound (<bold>3</bold>) and compound (<bold>4</bold>). This is an initial report of their isolation from <italic>Polygonum salicifolium</italic>.</p><p>The anti-kinetoplastid activities of the compounds isolated from <italic>P. salicifolium</italic> indicate that flavanones <bold>3</bold> and <bold>4</bold> displayed a moderate activity against <italic>Trypanosoma</italic> species, and their activity against <italic>Leishmania</italic> promastigotes was poor. However, chalcone <bold>1</bold> displayed a promising activity against <italic>T. b. brucei</italic> at ~2 &#x000b5;M, as well as a moderate activity against <italic>T. congolense</italic> and a reasonable activity against <italic>L. mexicana</italic>. No cross-resistance with the current trypanocides was observed, which is very important, as resistance to the old anti-kinetoplastid drugs is a key driver of the need for new treatments [<xref rid="B11-pathogens-10-00175" ref-type="bibr">11</xref>,<xref rid="B12-pathogens-10-00175" ref-type="bibr">12</xref>,<xref rid="B18-pathogens-10-00175" ref-type="bibr">18</xref>]. The consistently lower anti-protozoal activity of chalcone <bold>2</bold> suggests that a systematic investigation of the structure&#x02013;activity relationship of chalcones, including substitutions on the chalcone rings, could yield compounds with substantially improved efficacy against parasites. Importantly, neither of the chalcones showed toxicity against the human cell line HFF at 100 &#x000b5;g/mL, and the in vitro selectivity index of 1 was &#x0003e;172. An important advantage of the chalcones over the flavanones is that their synthesis, and thus SAR, should be more accessible than that of most natural compounds because of the lack of chiral centers [<xref rid="B33-pathogens-10-00175" ref-type="bibr">33</xref>].</p></sec><sec id="sec4-pathogens-10-00175"><title>4. Materials and Methods</title><sec id="sec4dot1-pathogens-10-00175" sec-type="methods"><title>4.1. General Experimental Procedures</title><p>The <sup>1</sup>H and <sup>13</sup>C NMR spectra were run on a Bruker AVANCE III 500 MHz spectrophotometer, operating at 500 MHz (<sup>1</sup>H) and 125 MHz (<sup>13</sup>C), respectively, using CDCl<sub>3</sub> as the solvent and TMS as the internal standard. The mass spectra were recorded using a Thermo LTQ Orbitrap, while the exact masses were determined using a Thermo Exactive Orbitrap mass spectrometer. Column chromatographic separations were performed in glass columns using silica gel MN-60 (Macherey-Nagel GmbH, KG, D&#x000fc;ren, Germany). TLC and PTLC were carried out using pre-coated silica gel 60 Aluminium sheets (Merck Chemicals, Bedfont Lakes Business Park Feltham, U.K.). The spots on the TLC were visualized using an anisaldehyde-H<sub>2</sub>SO<sub>4</sub> reagent. Solvents, hexane, ethyl acetate, and methanol were purchased from Sigma-Aldrich, U.K.</p></sec><sec id="sec4dot2-pathogens-10-00175"><title>4.2. Collection of Plant Material</title><p>The plant <italic>P. salicifolium</italic> Brouss ex Wild was collected from the banks of the River Tigris in Southern Iraq in April 2015, and was identified and deposited at the College of Science, University of Diyala by Assist. Prof. Dr Khazal Dh. Wadi Al-Jibouri.</p></sec><sec id="sec4dot3-pathogens-10-00175"><title>4.3. Preparation of Extracts</title><p>The aerial parts of the plant were dried and finely powdered with an IKA grinder (IKA Werke GmbH and Co. KG, Staufen im Breisgau, Germany). The ground material (50 g) was extracted (500 mL, 72 h each) with hexane, ethyl acetate (EtOAc), and then methanol (MeOH) using a Soxhlet apparatus. The extracts were then filtered and dried at 40 &#x000b0;C using a rotary evaporator (B&#x000fc;chi, Flawil, Switzerland).</p></sec><sec id="sec4dot4-pathogens-10-00175"><title>4.4. Isolation and Identification of Compounds</title><p>The hexane extract (1 g; 2% yield) was subjected to silica gel column chromatography eluting gradient wise with hexane, followed by increasing amounts (10&#x02013;90% <italic>v</italic>/<italic>v</italic>) of EtOAc in hexane and then EtOAc (100%). A total of 150 fractions (5 mL each) were collected and, based on TLC results, similar fractions were combined. Further purification of the compounds was carried out using preparative thin layer chromatography (PTLC) with 30&#x02013;70% (<italic>v</italic>/<italic>v</italic>) EtOAc in hexane and 10% (<italic>v</italic>/<italic>v</italic>) MeOH in EtOAc. The characterization of the compounds was carried out using NMR (1D and 2D) on a Bruker AVIII HD 500 spectrophotometer using 5&#x02013;20 mg samples dissolved in chloroform-<italic>d</italic>. The ethyl acetate and methanol extracts did not yield any significant results in the preliminary assays and spectroscopic analysis, and were thus not purified any further.</p></sec><sec id="sec4dot5-pathogens-10-00175"><title>4.5. Parasites and Cultures</title><p><italic>T. b. brucei</italic> strain Lister 427 (427-WT) was used as the standard drug-sensitive (wild-type; WT) laboratory strain [<xref rid="B34-pathogens-10-00175" ref-type="bibr">34</xref>]. This strain was previously adapted for multi-drug resistance by deletion of the TbAT1/P2 drug transporter [<xref rid="B35-pathogens-10-00175" ref-type="bibr">35</xref>], subsequently followed by in vitro exposure to increasing concentrations of pentamidine [<xref rid="B28-pathogens-10-00175" ref-type="bibr">28</xref>]. For <italic>T. congolense</italic>, the culture-adapted Savannah strain IL3000 was used [<xref rid="B22-pathogens-10-00175" ref-type="bibr">22</xref>], as well as a clonal line, 6C3, adapted from IL3000 in vitro to diminazene aceturate (Sigma), leading to a ~10-fold resistance. All <italic>Trypanosoma</italic> strains were cultured and used as bloodstream forms; <italic>T. b. brucei</italic> in a full HMI-9 medium supplemented with 10% Foetal Bovine Serum (FBS) [<xref rid="B27-pathogens-10-00175" ref-type="bibr">27</xref>] and <italic>T. congolense</italic> in TC-BSF1 medium with 20% goat serum at 34 &#x000b0;C, as described by Coustou et al. [<xref rid="B36-pathogens-10-00175" ref-type="bibr">36</xref>]. The promastigotes of <italic>L. mexicana</italic> strain MNY/BZ/62/M379 were cultured at 25 &#x000b0;C in a minimal essential medium, HO-MEMO-MEME, supplemented with 10% FBS and 1% of a penicillin/streptomycin solution (Gibco), as described previously [<xref rid="B37-pathogens-10-00175" ref-type="bibr">37</xref>,<xref rid="B38-pathogens-10-00175" ref-type="bibr">38</xref>].</p></sec><sec id="sec4dot6-pathogens-10-00175"><title>4.6. Anti-Protozoal Drug Testing</title><p>The anti-trypanosomal activity of the compounds was tested using the Alamar Blue (resazurin) assay in plastic 96-well plates, as described [<xref rid="B39-pathogens-10-00175" ref-type="bibr">39</xref>]. The assay was based on the reduction of blue, non-fluorescent resazurin sodium salt (Sigma) by live, but not by dead cells, to the red fluorescent metabolite resorufin [<xref rid="B40-pathogens-10-00175" ref-type="bibr">40</xref>]. Briefly, dilutions of the test compounds and control drugs were distributed in the first wells of the respective plate rows, and doubling dilution was carried out over two rows in the appropriate medium for <italic>T. b. brucei</italic> or <italic>T. congolense</italic>, leaving the last rows as the drug-free negative control (i.e., 23 doubling dilutions). Then, 10<sup>5</sup> trypanosomes were added to each well, followed by incubation of the plates at 37 &#x000b0;C/5% CO<sub>2</sub> (<italic>T. b. brucei</italic>) or 34.5 &#x000b0;C/5% CO<sub>2</sub> (<italic>T. congolense</italic>) for 48 h before the addition of the resazurin dye (20 &#x000b5;L of 125 mg/L), and a further incubation under the same conditions for 24 h. The <italic>T. congolense</italic> IL3000 WT and the diminazene resistant <italic>T. congolense</italic> IL3000 DA-Res (previously adapted to diminazene; clone 6C3) were utilized. Fluorescence was measured using a FLUOstar Optima plate reader at excitation and emission wavelengths of 544&#x02009;nm and 590&#x02009;nm, respectively, and the EC<sub>50</sub> of the compounds was then calculated using GraphPad Prism 5, using an equation for a sigmoid curve with a variable slope. The assay for <italic>L. mexicana</italic> promastigotes was performed as for <italic>T. b. brucei</italic> [<xref rid="B41-pathogens-10-00175" ref-type="bibr">41</xref>], except that incubation times of 72 h and 48 h were used before and after the addition of resazurin, respectively, because of the slower metabolism of the dye by <italic>Leishmania</italic> promastigotes [<xref rid="B40-pathogens-10-00175" ref-type="bibr">40</xref>].</p></sec><sec id="sec4dot7-pathogens-10-00175"><title>4.7. Drug Toxicity Assay</title><p>Toxicity of drugs to mammalian cells was carried out in the human cell line HFF, using a previously described method [<xref rid="B41-pathogens-10-00175" ref-type="bibr">41</xref>], with slight modifications. Briefly, HFF cells were grown in a medium consisting of 500 mL Dulbecco&#x02019;s Modified Eagle&#x02019;s Medium (DMEM; Sigma), 50 mL new-born calf serum (NBCS; Gibco, Cleveland, TN, USA), 5 mL penicillin/streptomycin (Gibco), and 5 mL L-Glutamax (200 mM, Gibco), at 37 &#x000b0;C/5% CO<sub>2</sub> up to ~80% confluence in vented flasks. For the assay, 100 &#x000b5;L of the cell suspension (3 &#x000d7; 10<sup>5</sup> cells/mL) was added to each well of a 96-well plate. The plate was incubated at 37 &#x000b0;C/5% CO<sub>2</sub> for 24 h to allow for cell adhesion, after which 100 &#x000b5;L of a serial drug dilution was added (prepared in a separate sterile plate). Phenylarsine oxide (PAO; Sigma) was used as the positive control. The cells were then incubated for a further 30 h before the addition of 10 &#x000b5;L of 125 mg/L resazurin solution, and underwent a final incubation for 24 h. Fluorescence measurements and data analysis were performed, as described above. The selectivity index was calculated as EC<sub>50</sub> (HFF)/EC<sub>50</sub>(427-WT).</p></sec></sec><sec sec-type="conclusions" id="sec5-pathogens-10-00175"><title>5. Conclusions</title><p>The present data showed that chalcones exhibited interesting activity against <italic>T. b. brucei</italic>; <italic>T. congolense;</italic> and, to a lesser extent, <italic>L. mexicana,</italic> and provide further evidence for the potential uses of natural plant extracts for combating these global parasitic diseases. Future work should concentrate on exploring the SAR of anti-protozoal chalcones and identifying their cellular targets. In addition, future research should test for the potential activity of <italic>P. salicifolium</italic> extracts against different protozoan species of medical and veterinary importance.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s Note:</bold> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><app-group><app id="app1-pathogens-10-00175"><title>Supplementary Materials</title><p>The following are available online at <uri xlink:href="https://www.mdpi.com/2076-0817/10/2/175/s1">https://www.mdpi.com/2076-0817/10/2/175/s1</uri>: Figures Spectrum S1&#x02013;S24 and Tables S1&#x02013;S4.</p><supplementary-material content-type="local-data" id="pathogens-10-00175-s001"><media xlink:href="pathogens-10-00175-s001.pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></app></app-group><notes><title>Author Contributions</title><p>D.G.W., J.O.I., A.I.G., H.P.d.K. and V.A.F. were involved in the conception of the research idea and performed the methodology design, supervision, data analysis, and interpretation. A.M.Z., S.A., E.K.E., M.A.U. and A.H.A. participated in the methodology, sampling, and data analysis. H.P.d.K. drafted and prepared the manuscript for publication and revision. The funders had no role in the data collection and analysis, decision to publish, or preparation of the manuscript. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Funding</title><p>E.K.E. was funded through a Newton-Mosharafa Researcher Links Travel Grant awarded through a collaboration between the U.K. government and the Egyptian government, represented by the Science Technology Development Fund (STDF). M.A.U. is funded through a studentship from the Petroleum Technology Development Fund (PTDF), Abuja, Nigeria. We thank the University of Misan, Amarah, Iraq, and the Ministry of Higher Education and Scientific Research of Iraq, for funding the PhD studentship of A.Z. The University of Albaha, Albaha, Saudi Arabia, funded the studentship of A.H.A.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare that they have no conflict of interest.</p></notes><ref-list><title>References</title><ref id="B1-pathogens-10-00175"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Mudaffar Fawzi</surname><given-names>N.</given-names></name><name><surname>Goodwin</surname><given-names>K.P.</given-names></name><name><surname>Mahdi</surname><given-names>B.A.</given-names></name><name><surname>Stevens</surname><given-names>M.L.</given-names></name></person-group><article-title>Effects of Mesopotamian Marsh (Iraq) desiccation on the cultural knowledge and livelihood of Marsh Arab women</article-title><source>Ecosyst. Health Sustain.</source><year>2016</year><volume>2</volume><fpage>e01207</fpage><pub-id pub-id-type="doi">10.1002/ehs2.1207</pub-id></element-citation></ref><ref id="B2-pathogens-10-00175"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hamdan</surname><given-names>M.A.</given-names></name><name><surname>Asada</surname><given-names>T.</given-names></name><name><surname>Hassan</surname><given-names>F.M.</given-names></name><name><surname>Warner</surname><given-names>B.G.</given-names></name><name><surname>Douabul</surname><given-names>A.</given-names></name><name><surname>Al-Hilli</surname><given-names>M.R.</given-names></name><name><surname>Alwan</surname><given-names>A.</given-names></name></person-group><article-title>Vegetation response to re-flooding in the Mesopotamian Wetlands, Southern Iraq</article-title><source>Wetlands</source><year>2010</year><volume>30</volume><fpage>177</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1007/s13157-010-0035-9</pub-id></element-citation></ref><ref id="B3-pathogens-10-00175"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calis</surname><given-names>I.</given-names></name><name><surname>Kuru&#x000fc;z&#x000fc;m</surname><given-names>A.</given-names></name><name><surname>Demirezer</surname><given-names>L.&#x000d6;.</given-names></name><name><surname>Sticher</surname><given-names>O.</given-names></name><name><surname>Ganci</surname><given-names>W.</given-names></name><name><surname>R&#x000fc;edi</surname><given-names>P.</given-names></name></person-group><article-title>Phenylvaleric Acid and Flavonoid Glycosides from <italic>Polygonum salicifolium</italic></article-title><source>J. Nat. Prod.</source><year>1999</year><volume>62</volume><fpage>1101</fpage><lpage>1105</lpage><pub-id pub-id-type="doi">10.1021/np9900674</pub-id><?supplied-pmid 10479312?><pub-id pub-id-type="pmid">10479312</pub-id></element-citation></ref><ref id="B4-pathogens-10-00175"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hussein</surname><given-names>S.R.</given-names></name><name><surname>Mohamed</surname><given-names>A.A.</given-names></name></person-group><article-title>Antioxidant activity and phenolic profiling of two Egyptian medicinal herbs <italic>Polygonum salicifolium</italic> Brouss ex Wild and Polygonum senegalense Meisn</article-title><source>An. Univ. din Oradea Fasc. Biol.</source><year>2013</year><volume>20</volume><fpage>59</fpage><lpage>63</lpage></element-citation></ref><ref id="B5-pathogens-10-00175"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Midiwo</surname><given-names>J.O.</given-names></name><name><surname>Yenesew</surname><given-names>A.</given-names></name><name><surname>Juma</surname><given-names>B.</given-names></name><name><surname>Derese</surname><given-names>S.</given-names></name><name><surname>Ayoo</surname><given-names>J.</given-names></name><name><surname>Aluoch</surname><given-names>A.</given-names></name><name><surname>Guchu</surname><given-names>S.</given-names></name></person-group><article-title>Bioactive compounds from some Kenyan ethnomedicinal plants: Myrsinaceae, Polygonaceae and <italic>Psiadia punctulata</italic></article-title><source>Phytochem. Rev.</source><year>2002</year><volume>1</volume><fpage>311</fpage><lpage>323</lpage><pub-id pub-id-type="doi">10.1023/A:1026029609500</pub-id></element-citation></ref><ref id="B6-pathogens-10-00175"><label>6.</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kokwaro</surname><given-names>J.O.</given-names></name></person-group><source>Medicinal Plants of East Africa</source><publisher-name>East African Publishing Bureau</publisher-name><publisher-loc>Nairobi, Kenya</publisher-loc><year>1976</year></element-citation></ref><ref id="B7-pathogens-10-00175"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Calder&#x000f3;n</surname><given-names>A.I.</given-names></name><name><surname>Simithy-Williams</surname><given-names>J.</given-names></name><name><surname>Gupta</surname><given-names>M.P.</given-names></name></person-group><article-title>Antimalarial natural products drug discovery in Panama</article-title><source>Pharm. Biol.</source><year>2012</year><volume>50</volume><fpage>61</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.3109/13880209.2011.602417</pub-id><pub-id pub-id-type="pmid">22196582</pub-id></element-citation></ref><ref id="B8-pathogens-10-00175"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hu</surname><given-names>Y.</given-names></name><name><surname>Ji</surname><given-names>J.</given-names></name><name><surname>Ling</surname><given-names>F.</given-names></name><name><surname>Chen</surname><given-names>Y.</given-names></name><name><surname>Lu</surname><given-names>L.</given-names></name><name><surname>Zhang</surname><given-names>Q.</given-names></name><name><surname>Wang</surname><given-names>G.</given-names></name></person-group><article-title>Screening medicinal plants for use against <italic>Dactylogyrus intermedius</italic> (Monogenea) infection in goldfish</article-title><source>J. Aquat. Anim. Health</source><year>2014</year><volume>26</volume><fpage>127</fpage><lpage>136</lpage><pub-id pub-id-type="doi">10.1080/08997659.2014.902872</pub-id><?supplied-pmid 25229482?><pub-id pub-id-type="pmid">25229482</pub-id></element-citation></ref><ref id="B9-pathogens-10-00175"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>G&#x000fc;ra&#x0011f;a&#x000e7; Dereli</surname><given-names>F.T.</given-names></name><name><surname>Ilhan</surname><given-names>M.</given-names></name><name><surname>Kozan</surname><given-names>E.</given-names></name><name><surname>K&#x000fc;peli Akkol</surname><given-names>E.</given-names></name></person-group><article-title>Effective eradication of pinworms (<italic>Syphacia obvelata</italic> and <italic>Aspiculuris tetraptera</italic>) with <italic>Polygonum cognatum</italic> Meissn</article-title><source>Exp. Parasitol.</source><year>2019</year><volume>196</volume><fpage>63</fpage><lpage>67</lpage><pub-id pub-id-type="doi">10.1016/j.exppara.2018.09.006</pub-id><?supplied-pmid 30237049?><pub-id pub-id-type="pmid">30237049</pub-id></element-citation></ref><ref id="B10-pathogens-10-00175"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhou</surname><given-names>S.Y.</given-names></name><name><surname>Liu</surname><given-names>Y.M.</given-names></name><name><surname>Zhang</surname><given-names>Q.Z.</given-names></name><name><surname>Fu</surname><given-names>Y.W.</given-names></name><name><surname>Lin</surname><given-names>D.J.</given-names></name></person-group><article-title>Evaluation of an antiparasitic compound extracted from <italic>Polygonum cuspidatum</italic> against <italic>Ichthyophthirius multifiliis</italic> in grass carp</article-title><source>Vet. Parasitol.</source><year>2018</year><volume>253</volume><fpage>22</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.vetpar.2018.02.005</pub-id><pub-id pub-id-type="pmid">29604998</pub-id></element-citation></ref><ref id="B11-pathogens-10-00175"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>The drugs of sleeping sickness: Their mechanisms of action and resistance, and a brief history</article-title><source>Trop. Med. Infect. Dis.</source><year>2020</year><volume>5</volume><elocation-id>14</elocation-id><pub-id pub-id-type="doi">10.3390/tropicalmed5010014</pub-id><?supplied-pmid 31963784?><pub-id pub-id-type="pmid">31963784</pub-id></element-citation></ref><ref id="B12-pathogens-10-00175"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Giordani</surname><given-names>F.</given-names></name><name><surname>Morrison</surname><given-names>L.J.</given-names></name><name><surname>Rowan</surname><given-names>T.G.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name><name><surname>Barrett</surname><given-names>M.P.</given-names></name></person-group><article-title>The animal trypanosomiases and their chemotherapy: A review</article-title><source>Parasitology</source><year>2016</year><volume>143</volume><fpage>1862</fpage><lpage>1889</lpage><pub-id pub-id-type="doi">10.1017/S0031182016001268</pub-id><pub-id pub-id-type="pmid">27719692</pub-id></element-citation></ref><ref id="B13-pathogens-10-00175"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tabbabi</surname><given-names>A.</given-names></name></person-group><article-title>Review of leishmaniasis in the Middle East and North Africa</article-title><source>Afr. Health Sci.</source><year>2019</year><volume>19</volume><fpage>1329</fpage><lpage>1337</lpage><pub-id pub-id-type="doi">10.4314/ahs.v19i1.4</pub-id><pub-id pub-id-type="pmid">31148958</pub-id></element-citation></ref><ref id="B14-pathogens-10-00175"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monge-Maillo</surname><given-names>B.</given-names></name><name><surname>Norman</surname><given-names>F.F.</given-names></name><name><surname>Cruz</surname><given-names>I.</given-names></name><name><surname>Alvar</surname><given-names>J.</given-names></name><name><surname>Lopez-Velez</surname><given-names>R.</given-names></name></person-group><article-title>Visceral leishmaniasis and HIV coinfection in the Mediterranean region</article-title><source>PLoS Negl. Trop. Dis.</source><year>2014</year><volume>8</volume><elocation-id>e3021</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0003021</pub-id><?supplied-pmid 25144380?><pub-id pub-id-type="pmid">25144380</pub-id></element-citation></ref><ref id="B15-pathogens-10-00175"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babuadze</surname><given-names>G.</given-names></name><name><surname>Alvar</surname><given-names>J.</given-names></name><name><surname>Argaw</surname><given-names>D.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name><name><surname>Iosava</surname><given-names>M.</given-names></name><name><surname>Kekelidze</surname><given-names>M.</given-names></name><name><surname>Tsertsvadze</surname><given-names>N.</given-names></name><name><surname>Tsereteli</surname><given-names>D.</given-names></name><name><surname>Chakhunashvili</surname><given-names>G.</given-names></name><name><surname>Mamatsashvili</surname><given-names>T.</given-names></name></person-group><article-title>Epidemiology of visceral leishmaniasis in Georgia</article-title><source>PLoS Negl. Trop. Dis.</source><year>2014</year><volume>8</volume><elocation-id>e2725</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0002725</pub-id><pub-id pub-id-type="pmid">24603768</pub-id></element-citation></ref><ref id="B16-pathogens-10-00175"><label>16.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Babuadze</surname><given-names>G.</given-names></name><name><surname>Farlow</surname><given-names>J.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name><name><surname>Carrillo</surname><given-names>E.</given-names></name><name><surname>Chakhunashvili</surname><given-names>G.</given-names></name><name><surname>Murskvaladze</surname><given-names>M.</given-names></name><name><surname>Kekelidze</surname><given-names>M.</given-names></name><name><surname>Karseladze</surname><given-names>I.</given-names></name><name><surname>Kokaia</surname><given-names>N.</given-names></name><name><surname>Kalandadze</surname><given-names>I.</given-names></name></person-group><article-title>Seroepidemiology and molecular diversity of <italic>Leishmania donovani</italic> complex in Georgia</article-title><source>Parasites Vectors</source><year>2016</year><volume>9</volume><fpage>279</fpage><pub-id pub-id-type="doi">10.1186/s13071-016-1558-6</pub-id><?supplied-pmid 27177688?><pub-id pub-id-type="pmid">27177688</pub-id></element-citation></ref><ref id="B17-pathogens-10-00175"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Delespaux</surname><given-names>V.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Drugs and drug resistance in African trypanosomiasis</article-title><source>Drug Resist. Updates</source><year>2007</year><volume>10</volume><fpage>30</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/j.drup.2007.02.004</pub-id></element-citation></ref><ref id="B18-pathogens-10-00175"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Burza</surname><given-names>S.</given-names></name><name><surname>Croft</surname><given-names>S.L.</given-names></name><name><surname>Boelaert</surname><given-names>M.</given-names></name></person-group><article-title>Leishmaniasis&#x02013;Authors&#x02019; reply</article-title><source>Lancet</source><year>2019</year><volume>393</volume><fpage>872</fpage><lpage>873</lpage><pub-id pub-id-type="doi">10.1016/S0140-6736(18)33057-5</pub-id></element-citation></ref><ref id="B19-pathogens-10-00175"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elmahallawy</surname><given-names>E.K.</given-names></name><name><surname>Agil</surname><given-names>A.</given-names></name></person-group><article-title>Treatment of leishmaniasis: A review and assessment of recent research</article-title><source>Curr. Pharm. Des.</source><year>2015</year><volume>21</volume><fpage>2259</fpage><lpage>2275</lpage><pub-id pub-id-type="doi">10.2174/1381612821666141231163053</pub-id><pub-id pub-id-type="pmid">25543123</pub-id></element-citation></ref><ref id="B20-pathogens-10-00175"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dike</surname><given-names>V.T.</given-names></name><name><surname>Vihiior</surname><given-names>B.</given-names></name><name><surname>Bosha</surname><given-names>J.A.</given-names></name><name><surname>Yin</surname><given-names>T.M.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name><name><surname>Igoli</surname><given-names>J.O.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name></person-group><article-title>Antitrypanosomal activity of a novel taccalonolide from the tubers of <italic>Tacca leontopetaloides</italic></article-title><source>Phytochem. Anal.</source><year>2016</year><volume>27</volume><fpage>217</fpage><lpage>221</lpage><pub-id pub-id-type="doi">10.1002/pca.2619</pub-id><pub-id pub-id-type="pmid">27313159</pub-id></element-citation></ref><ref id="B21-pathogens-10-00175"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Igoli</surname><given-names>J.O.</given-names></name><name><surname>Katsoulis</surname><given-names>E.</given-names></name><name><surname>Donachie</surname><given-names>A.-M.</given-names></name><name><surname>Eze</surname><given-names>A.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Bioassay-guided isolation of active principles from Nigerian medicinal plants identifies new trypanocides with low toxicity and no cross-resistance to diamidines and arsenicals</article-title><source>J. Ethnopharmacol.</source><year>2017</year><volume>202</volume><fpage>256</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.jep.2017.03.028</pub-id><pub-id pub-id-type="pmid">28336470</pub-id></element-citation></ref><ref id="B22-pathogens-10-00175"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Katsoulis</surname><given-names>E.</given-names></name><name><surname>Igoli</surname><given-names>J.O.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Multi-target mode of action of a Clerodane-type diterpenoid from <italic>Polyalthia longifolia</italic> targeting African trypanosomes</article-title><source>Sci. Rep.</source><year>2018</year><volume>8</volume><fpage>4613</fpage><pub-id pub-id-type="doi">10.1038/s41598-018-22908-3</pub-id><?supplied-pmid 29545637?><pub-id pub-id-type="pmid">29545637</pub-id></element-citation></ref><ref id="B23-pathogens-10-00175"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Ayuga</surname><given-names>T.D.</given-names></name><name><surname>Balogun</surname><given-names>E.O.</given-names></name><name><surname>Gil</surname><given-names>L.A.</given-names></name><name><surname>Donachie</surname><given-names>A.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Herraiz</surname><given-names>T.</given-names></name><name><surname>Inaoka</surname><given-names>D.K.</given-names></name><name><surname>Shiba</surname><given-names>T.</given-names></name><name><surname>Harada</surname><given-names>S.</given-names></name></person-group><article-title>Inhibition of trypanosome alternative oxidase without its N-terminal mitochondrial targeting signal (&#x00394;MTS-TAO) by cationic and non-cationic 4-hydroxybenzoate and 4-alkoxybenzaldehyde derivatives active against <italic>T. brucei</italic> and <italic>T. congolense</italic></article-title><source>Eur. J. Med. Chem.</source><year>2018</year><volume>150</volume><fpage>385</fpage><lpage>402</lpage><pub-id pub-id-type="doi">10.1016/j.ejmech.2018.02.075</pub-id><pub-id pub-id-type="pmid">29544150</pub-id></element-citation></ref><ref id="B24-pathogens-10-00175"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Omar</surname><given-names>R.</given-names></name><name><surname>Igoli</surname><given-names>J.O.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Clements</surname><given-names>C.J.</given-names></name><name><surname>Fearnley</surname><given-names>J.</given-names></name><name><surname>Ebel</surname><given-names>R.E.</given-names></name><name><surname>Paget</surname><given-names>T.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>The chemical characterization of Nigerian propolis samples and their activity against <italic>Trypanosoma brucei</italic></article-title><source>Sci. Rep.</source><year>2017</year><volume>7</volume><fpage>923</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-01038-2</pub-id><pub-id pub-id-type="pmid">28424496</pub-id></element-citation></ref><ref id="B25-pathogens-10-00175"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siheri</surname><given-names>W.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Igoli</surname><given-names>J.O.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>Biddau</surname><given-names>M.</given-names></name><name><surname>Akrachalanont</surname><given-names>P.</given-names></name><name><surname>Alenezi</surname><given-names>S.</given-names></name><name><surname>Alwashih</surname><given-names>M.A.</given-names></name><name><surname>Edrada-Ebel</surname><given-names>R.</given-names></name><name><surname>Muller</surname><given-names>S.</given-names></name></person-group><article-title>Isolation of a novel flavanonol and an alkylresorcinol with highly potent anti-trypanosomal activity from Libyan propolis</article-title><source>Molecules</source><year>2019</year><volume>24</volume><elocation-id>1041</elocation-id><pub-id pub-id-type="doi">10.3390/molecules24061041</pub-id><?supplied-pmid 30884752?><pub-id pub-id-type="pmid">30884752</pub-id></element-citation></ref><ref id="B26-pathogens-10-00175"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Siheri</surname><given-names>W.</given-names></name><name><surname>Zhang</surname><given-names>T.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Biddau</surname><given-names>M.</given-names></name><name><surname>Woods</surname><given-names>N.</given-names></name><name><surname>Hussain</surname><given-names>M.Y.</given-names></name><name><surname>Clements</surname><given-names>C.J.</given-names></name><name><surname>Fearnley</surname><given-names>J.</given-names></name><name><surname>Ebel</surname><given-names>R.E.</given-names></name><name><surname>Paget</surname><given-names>T.</given-names></name></person-group><article-title>Chemical and antimicrobial profiling of propolis from different regions within Libya</article-title><source>PLoS ONE</source><year>2016</year><volume>11</volume><elocation-id>e0155355</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0155355</pub-id><?supplied-pmid 27195790?><pub-id pub-id-type="pmid">27195790</pub-id></element-citation></ref><ref id="B27-pathogens-10-00175"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cerone</surname><given-names>M.</given-names></name><name><surname>Uliassi</surname><given-names>E.</given-names></name><name><surname>Prati</surname><given-names>F.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Lemgruber</surname><given-names>L.</given-names></name><name><surname>Bergamini</surname><given-names>C.</given-names></name><name><surname>Watson</surname><given-names>D.G.</given-names></name><name><surname>de AM Ferreira</surname><given-names>T.</given-names></name><name><surname>Roth Cardoso</surname><given-names>G.S.H.</given-names></name><name><surname>Soares Romeiro</surname><given-names>L.A.</given-names></name></person-group><article-title>Discovery of sustainable drugs for neglected tropical diseases: Cashew nut shell liquid (CNSL)-based hybrids target mitochondrial function and ATP production in <italic>Trypanosoma brucei</italic></article-title><source>ChemMedChem</source><year>2019</year><volume>14</volume><fpage>621</fpage><lpage>635</lpage><pub-id pub-id-type="doi">10.1002/cmdc.201800790</pub-id><pub-id pub-id-type="pmid">30664325</pub-id></element-citation></ref><ref id="B28-pathogens-10-00175"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jhoo</surname><given-names>J.</given-names></name><name><surname>Freeman</surname><given-names>J.P.</given-names></name><name><surname>Heinze</surname><given-names>T.M.</given-names></name><name><surname>Moody</surname><given-names>J.D.</given-names></name><name><surname>Schnackenberg</surname><given-names>R.K.</given-names></name><name><surname>Berger</surname><given-names>R.D.</given-names></name><name><surname>Dragull</surname><given-names>K.</given-names></name><name><surname>Tang</surname><given-names>C.</given-names></name><name><surname>Ang</surname><given-names>C.Y.W.</given-names></name></person-group><article-title>In vitro cytotoxicity of nononpolar constituents from different parts of kava plant (<italic>Piper methysticum</italic>)</article-title><source>J. Agric. Food Chem.</source><year>2006</year><volume>54</volume><fpage>3157</fpage><lpage>3162</lpage><pub-id pub-id-type="doi">10.1021/jf051853j</pub-id><?supplied-pmid 16608246?><pub-id pub-id-type="pmid">16608246</pub-id></element-citation></ref><ref id="B29-pathogens-10-00175"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzoyem</surname><given-names>J.P.</given-names></name><name><surname>NKuete</surname><given-names>A.H.</given-names></name><name><surname>Kuete</surname><given-names>V.</given-names></name><name><surname>Tala</surname><given-names>M.F.</given-names></name><name><surname>Wabo</surname><given-names>H.K.</given-names></name><name><surname>Guru</surname><given-names>S.K.</given-names></name><name><surname>Rajput</surname><given-names>V.S.</given-names></name><name><surname>Sharma</surname><given-names>A.</given-names></name><name><surname>Tane</surname><given-names>P.</given-names></name><name><surname>Khan</surname><given-names>I.A.</given-names></name></person-group><article-title>Cytotoxicity and antimicrobial activity of the methanol extract and compounds from <italic>Polyg. Limbatum</italic></article-title><source>Planta Med.</source><year>2012</year><volume>78</volume><fpage>787</fpage><lpage>792</lpage><?supplied-pmid 22495442?><pub-id pub-id-type="pmid">22495442</pub-id></element-citation></ref><ref id="B30-pathogens-10-00175"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dzoyem</surname><given-names>J.P.</given-names></name><name><surname>Nkuete</surname><given-names>A.H.</given-names></name><name><surname>Ngameni</surname><given-names>B.</given-names></name><name><surname>Eloff</surname><given-names>J.N.</given-names></name></person-group><article-title>Anti-inflammatory and anticholinesterase activity of six flavonoids isolated from <italic>Polygonum</italic> and <italic>Dorstenia</italic> species</article-title><source>Arch. Pharmacal. Res.</source><year>2017</year><volume>40</volume><fpage>1129</fpage><lpage>1134</lpage><pub-id pub-id-type="doi">10.1007/s12272-015-0612-9</pub-id><?supplied-pmid 26048035?><pub-id pub-id-type="pmid">26048035</pub-id></element-citation></ref><ref id="B31-pathogens-10-00175"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xuan</surname><given-names>T.D.</given-names></name><name><surname>Fukuta</surname><given-names>M.</given-names></name><name><surname>Wei</surname><given-names>A.C.</given-names></name><name><surname>Elzaawely</surname><given-names>A.A.</given-names></name><name><surname>Khanh</surname><given-names>T.D.</given-names></name><name><surname>Tawata</surname><given-names>S.</given-names></name></person-group><article-title>Efficacy of extracting solvents to chemical components of kava (<italic>Piper methysticum</italic>) roots</article-title><source>J. Nat. Med.</source><year>2008</year><volume>62</volume><fpage>188</fpage><pub-id pub-id-type="doi">10.1007/s11418-007-0203-2</pub-id><pub-id pub-id-type="pmid">18404321</pub-id></element-citation></ref><ref id="B32-pathogens-10-00175"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mitra</surname><given-names>A.K.</given-names></name><name><surname>Mawson</surname><given-names>A.R.</given-names></name></person-group><article-title>Neglected tropical diseases: Epidemiology and global burden</article-title><source>Trop. Med. Infect. Dis.</source><year>2017</year><volume>2</volume><elocation-id>36</elocation-id><pub-id pub-id-type="doi">10.3390/tropicalmed2030036</pub-id><?supplied-pmid 30270893?><pub-id pub-id-type="pmid">30270893</pub-id></element-citation></ref><ref id="B33-pathogens-10-00175"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Koning</surname><given-names>H.P.</given-names></name><name><surname>MacLeod</surname><given-names>A.</given-names></name><name><surname>Barrett</surname><given-names>M.P.</given-names></name><name><surname>Cover</surname><given-names>B.</given-names></name><name><surname>Jarvis</surname><given-names>S.M.</given-names></name></person-group><article-title>Further evidence for a link between melarsoprol resistance and P2 transporter function in African trypanosomes</article-title><source>Mol. Biochem. Parasitol.</source><year>2000</year><volume>106</volume><fpage>181</fpage><lpage>185</lpage><pub-id pub-id-type="doi">10.1016/S0166-6851(99)00206-6</pub-id><pub-id pub-id-type="pmid">10743623</pub-id></element-citation></ref><ref id="B34-pathogens-10-00175"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matovu</surname><given-names>E.</given-names></name><name><surname>Stewart</surname><given-names>M.L.</given-names></name><name><surname>Geiser</surname><given-names>F.</given-names></name><name><surname>Brun</surname><given-names>R.</given-names></name><name><surname>M&#x000e4;ser</surname><given-names>P.</given-names></name><name><surname>Wallace</surname><given-names>L.J.</given-names></name><name><surname>Burchmore</surname><given-names>R.J.</given-names></name><name><surname>Enyaru</surname><given-names>J.C.</given-names></name><name><surname>Barrett</surname><given-names>M.P.</given-names></name><name><surname>Kaminsky</surname><given-names>R.</given-names></name></person-group><article-title>Mechanisms of arsenical and diamidine uptake and resistance in <italic>Trypanosoma brucei</italic></article-title><source>Eukaryot. Cell</source><year>2003</year><volume>2</volume><fpage>1003</fpage><lpage>1008</lpage><pub-id pub-id-type="doi">10.1128/EC.2.5.1003-1008.2003</pub-id><pub-id pub-id-type="pmid">14555482</pub-id></element-citation></ref><ref id="B35-pathogens-10-00175"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coustou</surname><given-names>V.</given-names></name><name><surname>Guegan</surname><given-names>F.</given-names></name><name><surname>Plazolles</surname><given-names>N.</given-names></name><name><surname>Baltz</surname><given-names>T.</given-names></name></person-group><article-title>Complete in vitro life cycle of <italic>Trypanosoma congolense</italic>: Development of genetic tools</article-title><source>PLoS Negl. Trop. Dis.</source><year>2010</year><volume>4</volume><elocation-id>e618</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pntd.0000618</pub-id><?supplied-pmid 20209144?><pub-id pub-id-type="pmid">20209144</pub-id></element-citation></ref><ref id="B36-pathogens-10-00175"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Al-Salabi</surname><given-names>M.I.</given-names></name><name><surname>Wallace</surname><given-names>L.J.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>A <italic>Leishmania major</italic> nucleobase transporter responsible for allopurinol uptake is a functional homolog of the <italic>Trypanosoma brucei</italic> H2 transporter</article-title><source>Mol. Pharmacol.</source><year>2003</year><volume>63</volume><fpage>814</fpage><lpage>820</lpage><pub-id pub-id-type="doi">10.1124/mol.63.4.814</pub-id><pub-id pub-id-type="pmid">12644582</pub-id></element-citation></ref><ref id="B37-pathogens-10-00175"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzahrani</surname><given-names>K.J.</given-names></name><name><surname>Matyugina</surname><given-names>E.S.</given-names></name><name><surname>Khandazhinskaya</surname><given-names>A.L.</given-names></name><name><surname>Kochetkov</surname><given-names>S.N.</given-names></name><name><surname>Seley-Radtke</surname><given-names>K.L.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Evaluation of the antiprotozoan properties of 5&#x02032;-norcarbocyclic pyrimidine nucleosides</article-title><source>Bioorg. Med. Chem. Lett.</source><year>2017</year><volume>27</volume><fpage>3081</fpage><lpage>3086</lpage><pub-id pub-id-type="doi">10.1016/j.bmcl.2017.05.052</pub-id><?supplied-pmid 28571825?><pub-id pub-id-type="pmid">28571825</pub-id></element-citation></ref><ref id="B38-pathogens-10-00175"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Eze</surname><given-names>A.A.</given-names></name><name><surname>Igoli</surname><given-names>J.</given-names></name><name><surname>Gray</surname><given-names>A.I.</given-names></name><name><surname>Skellern</surname><given-names>G.G.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>The individual components of commercial isometamidium do not possess stronger trypanocidal activity than the mixture, nor bypass isometamidium resistance</article-title><source>Int. J. Parasitol. Drugs Drug Resist.</source><year>2019</year><volume>9</volume><fpage>54</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.ijpddr.2019.01.003</pub-id><pub-id pub-id-type="pmid">30685630</pub-id></element-citation></ref><ref id="B39-pathogens-10-00175"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gould</surname><given-names>M.K.</given-names></name><name><surname>Vu</surname><given-names>X.L.</given-names></name><name><surname>Seebeck</surname><given-names>T.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Propidium iodide-based methods for monitoring drug action in the kinetoplastidae: Comparison with the Alamar Blue assay</article-title><source>Anal. Biochem.</source><year>2008</year><volume>382</volume><fpage>87</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1016/j.ab.2008.07.036</pub-id><pub-id pub-id-type="pmid">18722997</pub-id></element-citation></ref><ref id="B40-pathogens-10-00175"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alzahrani</surname><given-names>K.J.</given-names></name><name><surname>Ali</surname><given-names>J.A.</given-names></name><name><surname>Eze</surname><given-names>A.A.</given-names></name><name><surname>Looi</surname><given-names>W.L.</given-names></name><name><surname>Tagoe</surname><given-names>D.N.</given-names></name><name><surname>Creek</surname><given-names>D.J.</given-names></name><name><surname>Barrett</surname><given-names>M.P.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Functional and genetic evidence that nucleoside transport is highly conserved in <italic>Leishmania</italic> species: Implications for pyrimidine-based chemotherapy</article-title><source>Int. J. Parasitol. Drugs Drug Resist.</source><year>2017</year><volume>7</volume><fpage>206</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1016/j.ijpddr.2017.04.003</pub-id><pub-id pub-id-type="pmid">28453984</pub-id></element-citation></ref><ref id="B41-pathogens-10-00175"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rodenko</surname><given-names>B.</given-names></name><name><surname>Wanner</surname><given-names>M.J.</given-names></name><name><surname>Alkhaldi</surname><given-names>A.A.</given-names></name><name><surname>Ebiloma</surname><given-names>G.U.</given-names></name><name><surname>Barnes</surname><given-names>R.L.</given-names></name><name><surname>Kaiser</surname><given-names>M.</given-names></name><name><surname>Brun</surname><given-names>R.</given-names></name><name><surname>McCulloch</surname><given-names>R.</given-names></name><name><surname>Koomen</surname><given-names>G.-J.</given-names></name><name><surname>De Koning</surname><given-names>H.P.</given-names></name></person-group><article-title>Targeting the parasite&#x02019;s DNA with methyltriazenyl purine analogs is a safe, selective, and efficacious antitrypanosomal strategy</article-title><source>Antimicrob. Agents Chemother.</source><year>2015</year><volume>59</volume><fpage>6708</fpage><lpage>6716</lpage><pub-id pub-id-type="doi">10.1128/AAC.00596-15</pub-id><pub-id pub-id-type="pmid">26282430</pub-id></element-citation></ref></ref-list></back><floats-group><fig id="pathogens-10-00175-f001" orientation="portrait" position="float"><label>Figure 1</label><caption><p>Structures of the test compounds isolated from <italic>Polygonum salicifolium</italic>.</p></caption><graphic xlink:href="pathogens-10-00175-g001"/></fig><table-wrap id="pathogens-10-00175-t001" orientation="portrait" position="float"><object-id pub-id-type="pii">pathogens-10-00175-t001_Table 1</object-id><label>Table 1</label><caption><p>Anti-kinetoplastid effects of the tested chalcones and flavanones.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">
</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>T. b. brucei</italic> EC<sub>50</sub><break/>(&#x000b5;M)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1"><italic>T. congolense</italic> EC<sub>50</sub><break/>(&#x000b5;M)</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1"><italic>L. mexicana</italic> EC<sub>50</sub> (&#x000b5;M)</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">HFF</th></tr><tr><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Compound</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">MW</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">427-WT</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">B48</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">IL3000-WT</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">DA-Res</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">WT</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">EC<sub>50</sub> (&#x000b5;M)</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SI (<italic>Tbb</italic>)</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">284.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.04 &#x000b1; 0.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.80 &#x000b1; 011</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8 &#x000b1; 0.39</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">8.8 &#x000b1; 0.28</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">18.2 &#x000b1; 1.0</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;172</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">14.6 &#x000b1; 0.80</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">13.9 &#x000b1; 0.60</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">34.0 &#x000b1; 1.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">28.6 &#x000b1; 1.4 *</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">83.6 &#x000b1; 0.7</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;330</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;22.8</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">284.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.1 &#x000b1; 0.95</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">30.3 &#x000b1; 1.1</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">137 &#x000b1; 10</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">106 &#x000b1; 15</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">271 &#x000b1; 31</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;350</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;11.7</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">300.3</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">55.3 &#x000b1; 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">51.9 &#x000b1; 1.6</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">63.3 &#x000b1; 7.9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">48.0 &#x000b1; 6.2</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">338 &#x000b1; 9</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;330</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;6.0</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Diminazene</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15 &#x000b1; 0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2.4 &#x000b1; 0.36 **</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.15 &#x000b1; 0.01</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.43 &#x000b1; 0.03 ***</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Pentamidine</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.0034 &#x000b1; 0.0004</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 &#x000b1; 0.03 ***</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.72 &#x000b1; 0.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">0.56 &#x000b1; 0.07</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PAO</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ND</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1.31 &#x000b1; 0.08</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">--</td></tr></tbody></table><table-wrap-foot><fn><p>All of the data listed are the average and standard error of the mean (SEM) of at least three independent determinations. PAO&#x02014;phenylarsine oxide; ND&#x02014;not done. Statistical significance was determined using an unpaired Student&#x02019;s <italic>t</italic>-test; * <italic>p</italic> &#x0003c; 0.05; ** <italic>p</italic> &#x0003c; 0.01; ***, <italic>p</italic> &#x0003c; 0.001. Selectivity index (SI) = EC<sub>50</sub>(HFF)/EC<sub>50</sub>(Tbb).</p></fn></table-wrap-foot></table-wrap></floats-group></article>